Clal Biotechnology Industries Ltd.

Informe acción TASE:CBI

Capitalización de mercado: ₪61.6m

Clal Biotechnology Industries Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Avi Fischer

Chief Executive Officer (CEO)

₪586.0k

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la dirección2.4yrs
Promedio de permanencia en la Junta Directiva6.9yrs

Actualizaciones recientes de la dirección

Recent updates

Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt

Oct 09
Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt

The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet

Apr 18
The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet

Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)

Jul 14
Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)

Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?

Jan 19
Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?

Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings

Mar 25
Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings

Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly

Mar 24
Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly

Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year

Feb 16
Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year

What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?

Jan 12
What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?

Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?

Dec 07
Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?

CEO

Avi Fischer (68 yo)

less than a year

Permanencia

₪586,000

Compensación

Dr. Avraham Matityahu Fischer, also known as Avi, M.D., is Co-Managing Partner of Fischer Behar Chen Well Orion & Co. Dr. Fischer is Deputy CEO, Executive VP and Deputy Chairman of Idb Development Corporat...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Avraham Fischer
Chairman & CEOless than a year₪586.00ksin datos
Liat Nissan
Chief Financial Officer2yrs₪975.00ksin datos
Iris Sadeh
Accountant2.8yrssin datossin datos
Shiran Manor
General Counsel & Corporate Secretaryno datasin datossin datos
Etty Kliger
Vice President of Research & Development - MediWoundno data₪1.10msin datos
Lior Rosenberg
Vice President of Medical Technologies - MediWoundno data₪1.21msin datos
Arnon Aharon
Medical Director2.8yrssin datossin datos

2.4yrs

Permanencia media

61.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CBI se considera experimentado (2.4 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Avraham Fischer
Chairman & CEO21.4yrs₪586.00ksin datos
Yuval Yanai
External Independent Director8.8yrssin datossin datos
Gonen Bieber
Directorless than a yearsin datossin datos
Gad Keren
Independent External Director4.7yrssin datossin datos
Gabriel Barabash
Director21.6yrssin datossin datos
Nufar Malovani
Director6.9yrssin datossin datos
Tomer Babai
Director6.8yrssin datossin datos

6.9yrs

Permanencia media

68yo

Promedio de edad

Junta con experiencia: La junta directiva de CBI se considera experimentada (6.9 años de antigüedad promedio).